Search CROs

• Cardiovascular & Metabolic Specialty Services
• In Vitro Pharmacology
• In Vivo Efficacy Models

Cardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications.

• Bioanalysis
• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services

Global full-service CRO specializing in early-phase and oncology trials across 50+ countries, with expertise in cardiovascular, cell and gene therapy, and radiopharmaceutical development.

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Clinical Operations

Full-service CRO specializing in Phase I–IV clinical trials across oncology, cardiovascular, metabolic, CNS, dermatological, infectious, and respiratory diseases, with global trial management capabilities and expertise in rare tumor research.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

PharPoint is a US-based CRO specializing in Phase I–IV clinical trials with rapid biometrics timelines, delivering database locks within 5 days of last patient visit and topline results in 2 business days.

• In Vivo Efficacy Models
• In Vivo PK / PD Studies
• Preclinical In Vivo Studies

Preclinical CRO with over 1,500 validated in vivo efficacy models spanning 100+ indications in oncology, immunology, inflammation, and bone disease. AAALAC-accredited vivarium with capacity for 30,000 rodents and 350 non-human primates supports IND filings to FDA and CFDA.

• Cardiovascular & Metabolic Specialty Services
• Central Laboratory Services
• Clinical Imaging Core Lab

Specialized cardiovascular CRO offering full-spectrum clinical development from protocol design through regulatory submission, with deep cardiology expertise and core laboratory services across all development phases.

• Analytical Method Development & Validation
• Bioanalysis
• Flow Cytometry Services

ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.

• Biomarker Assays
• Central Laboratory Services
• Clinical Trial Services

CLIA-certified CRO specializing in ultra-sensitive molecular analytics, custom immunology assays, and integrated virology-immunology workflows for cell therapies, gene editing, and infectious disease programs.

• Analytical Method Development & Validation
• China NMPA Regulatory Strategy
• EU EMA Regulatory Strategy

uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing. Headquartered in Maryland with operations across North America and Asia, the company specializes in bridging ATMP concepts from early…

• In Vitro Pharmacology
• In Vivo Efficacy Models
• Microbiology Services

Creative Diagnostics provides antiviral and antibacterial assays, cell-based compound screening, and in vivo model solutions with BSL-2 and BSL-3 capabilities for drug and vaccine development.

• Clinical Trial Services
• GLP Toxicology
• Preclinical In Vitro Studies

Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.

• Immunology & Inflammation Services
• In Vitro Pharmacology
• In Vivo Efficacy Models

Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.

• Computational & In-Silico Drug Discovery
• Discovery Research
• High-Throughput Screening

Integrated CRO-CDMO with 25+ years of discovery and development expertise across small and large molecules, operating 16 US FDA-inspected cGMP facilities across three manufacturing countries.

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Global bioanalytical, biomarker, and analytical sciences CRO with labs across four continents supporting all phases of drug development.

• Analytical Method Development & Validation
• Regulatory Affairs
• EU EMA Regulatory Strategy

Global CRO with over 15 years of experience in analytical testing integrated with scientific consultancy and regulatory compliance support across all stages of pharmaceutical development.

• Bioanalysis
• In Vivo PK / PD Studies
• LC-MS Bioanalysis (Small Molecule)

GLP-compliant bioanalytical CRO specializing in LC-MS/MS solutions for preclinical and clinical research, IND submissions, and new drug applications.

• Analytical Method Development & Validation
• Bioanalysis
• Microbiology Services

Full-service CRO delivering analytical, bioanalytical, and microbiology services across small molecules, biologics, gene therapy, and botanical drugs from discovery through clinical development.

• Analytical Method Development & Validation
• Medicinal Chemistry
• Regulatory Affairs

Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.